<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC160001_doc-4-5-17-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://salt.semanticauthoring.org/ontologies/sdo#Sentence> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC160001_doc-4-5-17-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasStartPointer>	"14179"^^<http://www.w3.org/2001/XMLSchema#long> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC160001_doc-4-5-17-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasOrderNumber>	"1"^^<http://www.w3.org/2001/XMLSchema#int> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC160001_doc-4-5-17-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasTextChunk>	<http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC160001_doc-4-5-17-1-14209-14218> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC160001_doc-4-5-17-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasTextChunk>	<http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC160001_doc-4-5-17-1-14219-14228> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC160001_doc-4-5-17-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasText>	"Kombinace vy\u017Eaduj\u00EDc\u00ED zvl\u00E1\u0161tn\u00ED pozornost\nSelegilin (selektivn\u00ED MAO-B inhibitor)\nFarmakokineticko/farmakodynamick\u00E1 interak\u010Dn\u00ED studie sou\u010Dasn\u00E9ho pod\u00E1v\u00E1n\u00ED citalopramu (20 mg denn\u011B) a selegilinu (10 mg denn\u011B) (selektivn\u00ED MAO-B inhibitor) neprok\u00E1zala klinicky v\u00FDznamn\u00E9 interakce."@cs .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC160001_doc-4-5-17-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasEndPointer>	"14452"^^<http://www.w3.org/2001/XMLSchema#long> .